Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.

MLA

Jiang, Kuikui, et al. “Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.” Cancer Research & Treatment, vol. 56, no. 2, Apr. 2024, pp. 513–21. EBSCOhost, https://doi.org/10.4143/crt.2023.786.

APA

Jiang, K., Hong, R., Xia, W., Lu, Q., Li, L., Huang, J., Shi, Y., Yuan, Z., Zheng, Q., An, X., Xue, C., Huang, J., Bi, X., Chen, M., Zhang, J., Xu, F., & Wang, S. (2024). Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study. Cancer Research & Treatment, 56(2), 513–521. https://doi.org/10.4143/crt.2023.786

Chicago

Jiang, Kuikui, Ruoxi Hong, Wen Xia, Qianyi Lu, Liang Li, Jianhao Huang, Yanxia Shi, et al. 2024. “Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study.” Cancer Research & Treatment 56 (2): 513–21. doi:10.4143/crt.2023.786.